Monogenic Neonatal Mody Gestational Diabetes Type 1 Type 2

General Gestational Diabetes Mellitus is a type of diabetes that results form glucose intolerance that takes place during pregnancy. Gestational diabetes results for the pancreatic beta cells incapability to the meet the insulin needs. Women are asked to receive testing for Gestational Diabetes around the time of 24 to 28 weeks of pregnancy, so they can be able to receive information on their risk level. A study done by the American Diabetes Association shows that “7% of all pregnancies are complicated by Gestational Diabetes, this then results to more than 200,000 cases per year.” [13]. Research by National Institutes of Health also say the “3 to 8 out of 100 women have this type of diabetes.” Women with Gestational diabetes and their children have a risk of developing another form of Diabetes. Besides the Risk factors of Gestational Diabetes (refer to Living with diabetes for Risk factors), Gestational Diabetes of different risk levels take 2 main approaches (American Diabetes Association): 1: Performance of a diagnostic oral glucose tolerance test (OGTT) before plasma glucose screening. 2: Performing a screening that measures the plasma concentration an hour after a 50-g oral glucose challenge test (GCT). OGTT may be performed if the glucose value is too much in GCT.